NATICK, Mass., May 4 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) announced today that it has filed a lawsuit in Ireland against Conor Medsystems Ireland Ltd. (NASDAQ: CONR), alleging that the Conor CoStar™ Paclitaxel-Eluting Coronary Stent System infringes a balloon catheter patent owned by Boston Scientific. Boston Scientific is asking for damages and an injunction to prohibit Conor from making, offering, putting on the market or stocking the product in Ireland. The asserted patent is the Irish counterpart of the European patent that Boston Scientific has successfully asserted against Johnson & Johnson in the Netherlands.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com/.

This press release contains forward-looking statements. Boston Scientific wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with new product development and commercialization, clinical trials, intellectual property, regulatory approvals, competitive offerings, integration of acquired companies, Boston Scientific's overall business strategy, and other factors described in Boston Scientific's filings with the Securities and Exchange Commission.

  CONTACT: Milan Kofol
           508-650-8569
           Investor Relations
           Boston Scientific Corporation

           Paul Donovan
           508-650-8541
           Media Relations
           Boston Scientific Corporation

SOURCE: Boston Scientific Corporation

CONTACT: Milan Kofol, Investor Relations, +1-508-650-8569, or Paul
Donovan, Media Relations, +1-508-650-8541, both of Boston Scientific
Corporation

Web site: http://www.bostonscientific.com/